Abrinca Genomics raised €160k in a funding round in Sep 2024. The company is based in Bern, Switzerland. Investors in the round: Venture Kick. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
